[18F]FDG PET/CT检测胸椎smarca4缺陷肿瘤。

IF 1.7 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Tsubasa Okazaki, Kota Yokoyama, Jyunichi Tsuchiya, Takayuki Honda, Yuya Ishikawa, Susumu Kirimura, Yasunari Miyazaki, Ukihide Tateishi
{"title":"[18F]FDG PET/CT检测胸椎smarca4缺陷肿瘤。","authors":"Tsubasa Okazaki,&nbsp;Kota Yokoyama,&nbsp;Jyunichi Tsuchiya,&nbsp;Takayuki Honda,&nbsp;Yuya Ishikawa,&nbsp;Susumu Kirimura,&nbsp;Yasunari Miyazaki,&nbsp;Ukihide Tateishi","doi":"10.1186/s41824-021-00102-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>SMARCA4-deficient thoracic tumor (SMARCA4-DTT) is a distinct entity of undifferentiated thoracic malignancies newly introduced in 2015. Due to its unique clinical characteristic with aggressive thoracic tumor mostly observed in heavy smoker man with emphysema, with poor prognosis, many physicians are becoming increasingly aware of the disease; however, reports on 2-deoxy-2-[<sup>18</sup>F] fluoroglucose positron emission tomography/computed tomography ([<sup>18</sup>F]FDG PET/CT) have been limited; thus, this disease is not yet widely known to nuclear medicine clinicians. As a first step in discussing the usefulness of [<sup>18</sup>F]FDG PET/CT for this disease, we present a case in which [<sup>18</sup>F]FDG PET/CT played a clinically important role.</p><p><strong>Case: </strong>A 74-year-old heavy smoker man with an anamnesis of severe emphysema characterized by pleural thickening and abnormal enhancement in CT underwent 18F-FDG PET/CT for further examination. [<sup>18</sup>F]FDG-avid pleural nodules infiltrating into the chest wall were detected and pathologically diagnosed as SMARCA4-DTT with biopsy.</p><p><strong>Conclusion: </strong>SMARCA4-deficient thoracic tumor should be considered in a [<sup>18</sup>F]FDG-avid aggressive thoracic tumor in heavy smoker men with emphysema.</p>","PeriodicalId":36160,"journal":{"name":"European Journal of Hybrid Imaging","volume":"5 1","pages":"8"},"PeriodicalIF":1.7000,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41824-021-00102-5","citationCount":"5","resultStr":"{\"title\":\"SMARCA4-deficient thoracic tumor detected by [<sup>18</sup>F]FDG PET/CT.\",\"authors\":\"Tsubasa Okazaki,&nbsp;Kota Yokoyama,&nbsp;Jyunichi Tsuchiya,&nbsp;Takayuki Honda,&nbsp;Yuya Ishikawa,&nbsp;Susumu Kirimura,&nbsp;Yasunari Miyazaki,&nbsp;Ukihide Tateishi\",\"doi\":\"10.1186/s41824-021-00102-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>SMARCA4-deficient thoracic tumor (SMARCA4-DTT) is a distinct entity of undifferentiated thoracic malignancies newly introduced in 2015. Due to its unique clinical characteristic with aggressive thoracic tumor mostly observed in heavy smoker man with emphysema, with poor prognosis, many physicians are becoming increasingly aware of the disease; however, reports on 2-deoxy-2-[<sup>18</sup>F] fluoroglucose positron emission tomography/computed tomography ([<sup>18</sup>F]FDG PET/CT) have been limited; thus, this disease is not yet widely known to nuclear medicine clinicians. As a first step in discussing the usefulness of [<sup>18</sup>F]FDG PET/CT for this disease, we present a case in which [<sup>18</sup>F]FDG PET/CT played a clinically important role.</p><p><strong>Case: </strong>A 74-year-old heavy smoker man with an anamnesis of severe emphysema characterized by pleural thickening and abnormal enhancement in CT underwent 18F-FDG PET/CT for further examination. [<sup>18</sup>F]FDG-avid pleural nodules infiltrating into the chest wall were detected and pathologically diagnosed as SMARCA4-DTT with biopsy.</p><p><strong>Conclusion: </strong>SMARCA4-deficient thoracic tumor should be considered in a [<sup>18</sup>F]FDG-avid aggressive thoracic tumor in heavy smoker men with emphysema.</p>\",\"PeriodicalId\":36160,\"journal\":{\"name\":\"European Journal of Hybrid Imaging\",\"volume\":\"5 1\",\"pages\":\"8\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2021-04-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1186/s41824-021-00102-5\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Hybrid Imaging\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s41824-021-00102-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Hybrid Imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41824-021-00102-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 5

摘要

背景:smarca4缺陷胸部肿瘤(SMARCA4-DTT)是2015年新发现的一种独特的未分化胸部恶性肿瘤。由于其独特的临床特点,侵袭性胸部肿瘤多见于重度吸烟者合并肺气肿,预后差,因此越来越多的医生认识到该病;然而,关于2-脱氧-2-[18F]氟葡萄糖正电子发射断层扫描/计算机断层扫描([18F]FDG PET/CT)的报道有限;因此,核医学临床医生尚未广泛了解这种疾病。作为讨论[18F]FDG PET/CT对该疾病有用性的第一步,我们提出了一个[18F]FDG PET/CT在临床上发挥重要作用的病例。病例:74岁男性重度吸烟者,以胸膜增厚和CT异常增强为特征,行18F-FDG PET/CT进一步检查。[18F]FDG-avid胸膜结节浸润胸壁,活检病理诊断为SMARCA4-DTT。结论:重度吸烟者合并肺气肿的[18F] fdg阳性侵袭性胸腔肿瘤应考虑smarca4缺陷胸腔肿瘤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

SMARCA4-deficient thoracic tumor detected by [<sup>18</sup>F]FDG PET/CT.

SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT.

Background: SMARCA4-deficient thoracic tumor (SMARCA4-DTT) is a distinct entity of undifferentiated thoracic malignancies newly introduced in 2015. Due to its unique clinical characteristic with aggressive thoracic tumor mostly observed in heavy smoker man with emphysema, with poor prognosis, many physicians are becoming increasingly aware of the disease; however, reports on 2-deoxy-2-[18F] fluoroglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) have been limited; thus, this disease is not yet widely known to nuclear medicine clinicians. As a first step in discussing the usefulness of [18F]FDG PET/CT for this disease, we present a case in which [18F]FDG PET/CT played a clinically important role.

Case: A 74-year-old heavy smoker man with an anamnesis of severe emphysema characterized by pleural thickening and abnormal enhancement in CT underwent 18F-FDG PET/CT for further examination. [18F]FDG-avid pleural nodules infiltrating into the chest wall were detected and pathologically diagnosed as SMARCA4-DTT with biopsy.

Conclusion: SMARCA4-deficient thoracic tumor should be considered in a [18F]FDG-avid aggressive thoracic tumor in heavy smoker men with emphysema.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Journal of Hybrid Imaging
European Journal of Hybrid Imaging Computer Science-Computer Science (miscellaneous)
CiteScore
3.40
自引率
0.00%
发文量
29
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信